Quince Therapeutics, Inc. Financial Flexibility Index
Quince Therapeutics, Inc. financial flexibility index. Quince Therapeutics, Inc. (QNCX) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-18.89 Million (operating CF $-18.89 Million minus capex $0.00) represents -1% of total liabilities ($15.51 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Quince Therapeutics, Inc. (2017–2025)
Financial flexibility index of Quince Therapeutics, Inc. from 2017 to 2025. Historical Financial Flexibility Index trend for Quince Therapeutics, Inc. across 9 annual periods. Check how high is Quince Therapeutics, Inc.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quince Therapeutics, Inc. Financial Flexibility Index by Year (2017–2025)
Quince Therapeutics, Inc. financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Quince Therapeutics, Inc.. For the full cash flow conversion analysis, see Quince Therapeutics, Inc. operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-41.07 Million | $-41.42 Million | $129.24 Million | ▲ +15.3% |
| 2024 | -0.38x | $-31.65 Million | $-31.90 Million | $84.33 Million | ▼ -96.9% |
| 2023 | -0.19x | $-18.13 Million | $-18.29 Million | $95.12 Million | ▲ +98.6% |
| 2022 | -13.24x | $-43.91 Million | $-44.04 Million | $3.32 Million | ▼ -208.8% |
| 2021 | -4.29x | $-62.75 Million | $-62.93 Million | $14.64 Million | ▼ -45.2% |
| 2020 | -2.95x | $-50.77 Million | $-50.82 Million | $17.20 Million | ▲ +21.0% |
| 2019 | -3.74x | $-33.22 Million | $-33.28 Million | $8.89 Million | ▲ +52.6% |
| 2018 | -7.88x | $-11.48 Million | $-11.70 Million | $1.46 Million | ▼ -2163.2% |
| 2017 | -0.35x | $-9.75 Million | $-9.83 Million | $28.00 Million | — |